APA (7th ed.) Citation

Tsai, M., Nery, E. S. M., Kerr, L., Khanna, R., Komori, M., Dennehy, E. B., . . . Winner, P. (2021). Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine. Clinical pharmacokinetics, 60(6), 819-828. https://doi.org/10.1007/s40262-020-00966-z

Chicago Style (17th ed.) Citation

Tsai, Max, Emel Serap Monkul Nery, Lisa Kerr, Rashna Khanna, Mika Komori, Ellen B. Dennehy, Darren Wilbraham, and Paul Winner. "Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine." Clinical Pharmacokinetics 60, no. 6 (2021): 819-828. https://doi.org/10.1007/s40262-020-00966-z.

MLA (9th ed.) Citation

Tsai, Max, et al. "Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine." Clinical Pharmacokinetics, vol. 60, no. 6, 2021, pp. 819-828, https://doi.org/10.1007/s40262-020-00966-z.